BURBANK, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Imaging3™, Inc. (OTCQB:IGNG) announced today that the three-year term of the
mandatory self-remediation measures ordered against the company by the United States District Court in Los Angeles in connection
with the consent agreement by and between the company and the SEC on July 25, 2014 is concluded.
Dane Medley, President & Principal Executive Officer, stated: “We are pleased with the progress we have made over the past three
years. Against all odds, Imaging3 has overcome frivolous—yet expensive— shareholder litigation, restructured its debts, become
current with all of its SEC reporting requirements, and raised much-needed capital, all with an unwavering focus on the task of
bringing the revolutionary SmartScan™ imaging technology to market.”
Scott Pancoast, Special Executive advisor to the company, added: “Imaging3 has survived a gauntlet of issues over the past
three years and has fought against many adversaries and non-believers. This company has always been focused, and will continue to
stay focused, on the goal of delivering our superior imaging technology to the world’s healthcare stage.”
About Imaging3 Inc.
Imaging3, Inc., founded in 1993, has developed a patented medical imaging technology, called SmartScan™, that
will produce 3D x-ray images, virtually in real time. The SmartScan technology will allow healthcare professionals to perform
diagnostic and therapeutic procedures more quickly and accurately, resulting in higher throughput for the clinicians and fewer
safety risks for the patient. In addition, Imaging3’s technology exposes patients to significantly less harmful radiation than
current imaging technologies such as CT scans, which the company believes will allow scans to be used in more pediatric
applications than are currently prescribed. The technology also allows for greater portability, easier installation, and a
significantly reduced cost burden for the healthcare system overall. Imaging3 is planning to submit a 510K application to the FDA
during 2017 in order to gain approval to commercialize the SmartScan technology.
Visit the company’s website at http://www.imaging3.com for detailed information about the Company’s technology.
Safe Harbor Statement
Imaging3 cautions you that any statement included in this press release that is not a description of
historical facts is a forward-looking statement. Many of these forward-looking statements contain the words "anticipate,"
"believe," "estimate," "may" "intend," "expect" and similar expressions. Actual results, performance or achievements could differ
materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking
statements are based largely on the expectations of the company and are subject to a number of risks and uncertainties inherent in
the Imaging3’s business, including, without limitation: the company may not ever obtain FDA approval for any of its devices; the
company may not be able to secure the funds necessary to support its product development plans; and the company may not ever
achieve the market success to sustain a profitable business. In addition, there are risks and uncertainties related to economic
recession or terrorist actions, competition from much larger imaging companies, technological obsolescence, unexpected costs and
delays, potential product liability claims, and many other factors. More detailed information about Imaging3 and the risk factors
that may affect the realization of forward-looking statements is set forth in the company’s filings with the Securities and
Exchange Commission, including the company’s Annual Report on Form 10-K and its Quarterly Report on Form 10-Q. Such documents may
be read free of charge on the SEC’s website at www.sec.gov. You are cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary
statement, and Imaging3 undertakes no obligation to revise or update this press release to reflect events or circumstances after
the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform
Act of 1995.
Investor Relations Contact: Dane Medley President info@imaging3.com
